These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective. Seifert M; Bera SC; van Nies P; Kirchdoerfer RN; Shannon A; Le TT; Meng X; Xia H; Wood JM; Harris LD; Papini FS; Arnold JJ; Almo S; Grove TL; Shi PY; Xiang Y; Canard B; Depken M; Cameron CE; Dulin D Elife; 2021 Oct; 10():. PubMed ID: 34617885 [TBL] [Abstract][Full Text] [Related]
3. Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action. Tchesnokov EP; Gordon CJ; Woolner E; Kocinkova D; Perry JK; Feng JY; Porter DP; Götte M J Biol Chem; 2020 Nov; 295(47):16156-16165. PubMed ID: 32967965 [TBL] [Abstract][Full Text] [Related]
4. RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19. Jiang Y; Yin W; Xu HE Biochem Biophys Res Commun; 2021 Jan; 538():47-53. PubMed ID: 32943188 [TBL] [Abstract][Full Text] [Related]
5. A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase. Zhao J; Guo S; Yi D; Li Q; Ma L; Zhang Y; Wang J; Li X; Guo F; Lin R; Liang C; Liu Z; Cen S Antiviral Res; 2021 Jun; 190():105078. PubMed ID: 33894278 [TBL] [Abstract][Full Text] [Related]
6. Theaflavin-3'-O-gallate a Black-tea Constituent Blocked SARS CoV-2 RNA dependant RNA Polymerase Active-site with Better Docking Results than Remdesivir. Banerjee A; Kanwar M; Maiti S Drug Res (Stuttg); 2021 Oct; 71(8):462-472. PubMed ID: 34517419 [TBL] [Abstract][Full Text] [Related]
8. Piece of the puzzle: Remdesivir disassembles the multimeric SARS-CoV-2 RNA-dependent RNA polymerase complex. Olotu FA; Omolabi KF; Soliman MES Cell Biochem Biophys; 2021 Jun; 79(2):175-187. PubMed ID: 33792836 [TBL] [Abstract][Full Text] [Related]
9. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326 [TBL] [Abstract][Full Text] [Related]
10. Potent toxic effects of Taroxaz-104 on the replication of SARS-CoV-2 particles. Rabie AM Chem Biol Interact; 2021 Jul; 343():109480. PubMed ID: 33887223 [TBL] [Abstract][Full Text] [Related]
11. RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery. Zhu W; Chen CZ; Gorshkov K; Xu M; Lo DC; Zheng W SLAS Discov; 2020 Dec; 25(10):1141-1151. PubMed ID: 32660307 [TBL] [Abstract][Full Text] [Related]
12. Remdesivir for the treatment of Covid-19: the value of biochemical studies. Götte M Curr Opin Virol; 2021 Aug; 49():81-85. PubMed ID: 34052732 [TBL] [Abstract][Full Text] [Related]
14. Incorporation efficiency and inhibition mechanism of 2'-substituted nucleotide analogs against SARS-CoV-2 RNA-dependent RNA polymerase. Yuan C; Goonetilleke EC; Unarta IC; Huang X Phys Chem Chem Phys; 2021 Sep; 23(36):20117-20128. PubMed ID: 34514487 [TBL] [Abstract][Full Text] [Related]
15. Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type. Mohammad A; Al-Mulla F; Wei DQ; Abubaker J Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34206274 [TBL] [Abstract][Full Text] [Related]
16. Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets. Maio N; Lafont BAP; Sil D; Li Y; Bollinger JM; Krebs C; Pierson TC; Linehan WM; Rouault TA Science; 2021 Jul; 373(6551):236-241. PubMed ID: 34083449 [TBL] [Abstract][Full Text] [Related]
17. Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin. Yin W; Luan X; Li Z; Zhou Z; Wang Q; Gao M; Wang X; Zhou F; Shi J; You E; Liu M; Wang Q; Jiang Y; Jiang H; Xiao G; Zhang L; Yu X; Zhang S; Eric Xu H Nat Struct Mol Biol; 2021 Mar; 28(3):319-325. PubMed ID: 33674802 [TBL] [Abstract][Full Text] [Related]
18. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study. Wakchaure PD; Ghosh S; Ganguly B J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493 [TBL] [Abstract][Full Text] [Related]
19. The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2. Jin Z; Wang H; Duan Y; Yang H Biochem Biophys Res Commun; 2021 Jan; 538():63-71. PubMed ID: 33288200 [TBL] [Abstract][Full Text] [Related]
20. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase. Bertolin AP; Weissmann F; Zeng J; Posse V; Milligan JC; Canal B; Ulferts R; Wu M; Drury LS; Howell M; Beale R; Diffley JFX Biochem J; 2021 Jul; 478(13):2425-2443. PubMed ID: 34198323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]